Anti-ANXA10

Y123270 by Applied Biological Materials Inc. (ABM) is a mouse monoclonal IgG2a antibody targeting fragment (aa/168-324) of ANXA10 (Annexin A10), validated for Western blot at 1:500 in HeLa lysate and for ELISA. Affinity purified, 100 µg/100 µl in PBS with 0.02% sodium azide. MBP is a registered vendor for Howard Hughes Medical Institute, Vanderbilt University, MD Anderson Cancer Center, and Eurofins, among other leading institutes across the USA.